BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24337630)

  • 1. HTRA2 variations in Taiwanese Parkinson's disease.
    Chen CM; Wu CH; Hsieh CH; Lin CH; Chen IC; Chen YC; Lee LC; Lee CM; Tseng YC; Lee-Chen GJ; Wu YR
    J Neural Transm (Vienna); 2014 May; 121(5):491-8. PubMed ID: 24337630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel variant Pro143Ala in HTRA2 contributes to Parkinson's disease by inducing hyperphosphorylation of HTRA2 protein in mitochondria.
    Lin CH; Chen ML; Chen GS; Tai CH; Wu RM
    Hum Genet; 2011 Dec; 130(6):817-27. PubMed ID: 21701785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variations of Omi/HTRA2 in Chinese patients with Parkinson's disease.
    Wang CY; Xu Q; Weng L; Zhang Q; Zhang HN; Guo JF; Tan LM; Tang JG; Yan XX; Tang BS
    Brain Res; 2011 Apr; 1385():293-7. PubMed ID: 21338583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATP13A2 variability in Taiwanese Parkinson's disease.
    Chen CM; Lin CH; Juan HF; Hu FJ; Hsiao YC; Chang HY; Chao CY; Chen IC; Lee LC; Wang TW; Chen YT; Chen YT; Lee-Chen GJ; Wu YR
    Am J Med Genet B Neuropsychiatr Genet; 2011 Sep; 156B(6):720-9. PubMed ID: 21714071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequencing analysis of OMI/HTRA2 shows previously reported pathogenic mutations in neurologically normal controls.
    Simón-Sánchez J; Singleton AB
    Hum Mol Genet; 2008 Jul; 17(13):1988-93. PubMed ID: 18364387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variation of Omi/HtrA2 and Parkinson's disease.
    Ross OA; Soto AI; Vilariño-Güell C; Heckman MG; Diehl NN; Hulihan MM; Aasly JO; Sando S; Gibson JM; Lynch T; Krygowska-Wajs A; Opala G; Barcikowska M; Czyzewski K; Uitti RJ; Wszolek ZK; Farrer MJ
    Parkinsonism Relat Disord; 2008 Nov; 14(7):539-43. PubMed ID: 18790661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease.
    Krüger R; Sharma M; Riess O; Gasser T; Van Broeckhoven C; Theuns J; Aasly J; Annesi G; Bentivoglio AR; Brice A; Djarmati A; Elbaz A; Farrer M; Ferrarese C; Gibson JM; Hadjigeorgiou GM; Hattori N; Ioannidis JP; Jasinska-Myga B; Klein C; Lambert JC; Lesage S; Lin JJ; Lynch T; Mellick GD; de Nigris F; Opala G; Prigione A; Quattrone A; Ross OA; Satake W; Silburn PA; Tan EK; Toda T; Tomiyama H; Wirdefeldt K; Wszolek Z; Xiromerisiou G; Maraganore DM;
    Neurobiol Aging; 2011 Mar; 32(3):548.e9-18. PubMed ID: 20036034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease.
    Strauss KM; Martins LM; Plun-Favreau H; Marx FP; Kautzmann S; Berg D; Gasser T; Wszolek Z; Müller T; Bornemann A; Wolburg H; Downward J; Riess O; Schulz JB; Krüger R
    Hum Mol Genet; 2005 Aug; 14(15):2099-111. PubMed ID: 15961413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What have PINK1 and HtrA2 genes told us about the role of mitochondria in Parkinson's disease?
    Plun-Favreau H; Gandhi S; Wood-Kaczmar A; Deas E; Yao Z; Wood NW
    Ann N Y Acad Sci; 2008 Dec; 1147():30-6. PubMed ID: 19076428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial defects and neurodegeneration in mice overexpressing wild-type or G399S mutant HtrA2.
    Casadei N; Sood P; Ulrich T; Fallier-Becker P; Kieper N; Helling S; May C; Glaab E; Chen J; Nuber S; Wolburg H; Marcus K; Rapaport D; Ott T; Riess O; Krüger R; Fitzgerald JC
    Hum Mol Genet; 2016 Feb; 25(3):459-71. PubMed ID: 26604148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial serine protease HTRA2 gene mutation in Asians with coexistent essential tremor and Parkinson disease.
    Chao YX; Ng EY; Foo JN; Liu J; Zhao Y; Tan EK
    Neurogenetics; 2015 Jul; 16(3):241-2. PubMed ID: 25791756
    [No Abstract]   [Full Text] [Related]  

  • 12. Investigating the role of 99mTc-TRODAT-1 SPECT imaging in idiopathic Parkinson's disease.
    Geng Y; Shi GH; Jiang Y; Xu LX; Hu XY; Shao YQ
    J Zhejiang Univ Sci B; 2005 Jan; 6(1):22-7. PubMed ID: 15593387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variant R244H in Na+/Mg2+ exchanger SLC41A1 in Taiwanese Parkinson's disease is associated with loss of Mg2+ efflux function.
    Lin CH; Wu YR; Chen WL; Wang HC; Lee CM; Lee-Chen GJ; Chen CM
    Parkinsonism Relat Disord; 2014 Jun; 20(6):600-3. PubMed ID: 24661466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin reverses TRAP1 mutation-associated alterations in mitochondrial function in Parkinson's disease.
    Fitzgerald JC; Zimprich A; Carvajal Berrio DA; Schindler KM; Maurer B; Schulte C; Bus C; Hauser AK; Kübler M; Lewin R; Bobbili DR; Schwarz LM; Vartholomaiou E; Brockmann K; Wüst R; Madlung J; Nordheim A; Riess O; Martins LM; Glaab E; May P; Schenke-Layland K; Picard D; Sharma M; Gasser T; Krüger R
    Brain; 2017 Sep; 140(9):2444-2459. PubMed ID: 29050400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic Role of Serine Protease HtrA2/Omi in Neurodegenerative Diseases.
    Goo HG; Rhim H; Kang S
    Curr Protein Pept Sci; 2017; 18(7):746-757. PubMed ID: 26965693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variability in the mitochondrial serine protease HTRA2 contributes to risk for Parkinson disease.
    Bogaerts V; Nuytemans K; Reumers J; Pals P; Engelborghs S; Pickut B; Corsmit E; Peeters K; Schymkowitz J; De Deyn PP; Cras P; Rousseau F; Theuns J; Van Broeckhoven C
    Hum Mutat; 2008 Jun; 29(6):832-40. PubMed ID: 18401856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered enzymatic activity and allele frequency of OMI/HTRA2 in Alzheimer's disease.
    Westerlund M; Behbahani H; Gellhaar S; Forsell C; Belin AC; Anvret A; Zettergren A; Nissbrandt H; Lind C; Sydow O; Graff C; Olson L; Ankarcrona M; Galter D
    FASEB J; 2011 Apr; 25(4):1345-52. PubMed ID: 21163861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early-onset Parkinson's disease in a Chinese population: 99mTc-TRODAT-1 SPECT, Parkin gene analysis and clinical study.
    Shyu WC; Lin SZ; Chiang MF; Pang CY; Chen SY; Hsin YL; Thajeb P; Lee YJ; Li H
    Parkinsonism Relat Disord; 2005 May; 11(3):173-80. PubMed ID: 15823482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of RAB39B mutations in early-onset and familial Parkinson's disease in a Taiwanese cohort.
    Lin HH; Wu RM; Lin HI; Chen ML; Tai CH; Lin CH
    Neurobiol Aging; 2017 Feb; 50():169.e3-169.e4. PubMed ID: 27838047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1.
    Plun-Favreau H; Klupsch K; Moisoi N; Gandhi S; Kjaer S; Frith D; Harvey K; Deas E; Harvey RJ; McDonald N; Wood NW; Martins LM; Downward J
    Nat Cell Biol; 2007 Nov; 9(11):1243-52. PubMed ID: 17906618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.